EP0991404A1 - Vorrichtung zur verabreichung von dermatologische wirkstoffe - Google Patents

Vorrichtung zur verabreichung von dermatologische wirkstoffe

Info

Publication number
EP0991404A1
EP0991404A1 EP97934853A EP97934853A EP0991404A1 EP 0991404 A1 EP0991404 A1 EP 0991404A1 EP 97934853 A EP97934853 A EP 97934853A EP 97934853 A EP97934853 A EP 97934853A EP 0991404 A1 EP0991404 A1 EP 0991404A1
Authority
EP
European Patent Office
Prior art keywords
skin
liquid
reservoir
shell
transfer pad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97934853A
Other languages
English (en)
French (fr)
Inventor
Richard L. Devillez
Laura J. Crane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRANE, LAURA J.
Bayer Consumer Care Holdings LLC
Original Assignee
Schering Plough Healthcare Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Healthcare Products Inc filed Critical Schering Plough Healthcare Products Inc
Publication of EP0991404A1 publication Critical patent/EP0991404A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
EP97934853A 1997-06-24 1997-06-24 Vorrichtung zur verabreichung von dermatologische wirkstoffe Withdrawn EP0991404A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/011062 WO1998058631A1 (en) 1997-06-24 1997-06-24 Device for delivery of dermatological ingredients

Publications (1)

Publication Number Publication Date
EP0991404A1 true EP0991404A1 (de) 2000-04-12

Family

ID=22261154

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97934853A Withdrawn EP0991404A1 (de) 1997-06-24 1997-06-24 Vorrichtung zur verabreichung von dermatologische wirkstoffe

Country Status (4)

Country Link
EP (1) EP0991404A1 (de)
AU (1) AU3791997A (de)
CA (1) CA2294067C (de)
WO (1) WO1998058631A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7195774B2 (en) * 2001-08-29 2007-03-27 Carvalho Ricardo Azevedo Ponte Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
EP2961734B1 (de) 2013-02-28 2018-09-26 Dermira, Inc. Glycopyrrolat-salze
US11607026B2 (en) 2014-05-30 2023-03-21 Johnson & Johnson Consumer Inc. Device for delivery of skin care composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4597961A (en) * 1985-01-23 1986-07-01 Etscorn Frank T Transcutaneous application of nicotine
CA1280111C (en) * 1985-04-03 1991-02-12 Richard E. Reever. Composition for transdermal drug delivery
US5045553A (en) * 1987-06-24 1991-09-03 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
WO1993003697A1 (en) * 1991-08-27 1993-03-04 Cygnus Therapeutic Systems Transdermal formulations for administering prazosin
US5460620A (en) * 1992-07-31 1995-10-24 Creative Products Resource, Inc. Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
AU5543196A (en) * 1995-04-12 1996-10-30 Robert B. Hopp Skin patch for use in contact immunotherapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9858631A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus

Also Published As

Publication number Publication date
WO1998058631A1 (en) 1998-12-30
AU3791997A (en) 1999-01-04
CA2294067A1 (en) 1998-12-30
CA2294067C (en) 2005-11-15

Similar Documents

Publication Publication Date Title
US5962011A (en) Device for delivery of dermatological ingredients
US5230898A (en) Transdermal therapeutic system exhibiting an increased active substance flow and process for the production thereof
AU2009233617B2 (en) Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
EP1225951B1 (de) Transdermale, in form einer haftschicht ausgebildete zweifachmedikamenten-verabreichungsvorrichtung
US5683711A (en) Active ingredient patch
RU2176499C2 (ru) Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат
CA2125662C (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
US5641507A (en) Delivery system for dermatological and cosmetic ingredients
KR910007548A (ko) 활성성분 플래스터, 그의 제조방법 및 용도
CA2294067C (en) Device for delivery of dermatological ingredients
EP0297828A1 (de) Mit Medikamenten versehene Verbände
CA2338859A1 (en) Estradiol-containing patch for transdermal administration of hormones
JP4938949B2 (ja) アセチルサリチル酸および／またはサリチル酸投与用の経皮治療システム
AU584025B2 (en) Bandage for sustained delivery of drugs
JP2003104875A (ja) 放出遅延型薬物投与デバイス
US5965155A (en) Transdermal therapeutic system with pentylene tetrazol as active substance
NZ258129A (en) Transdermal system for applying acetylsalicylic acid or salts thereof for antithrombotic treatment or cancer proplylaxis
KR100272043B1 (ko) 알쯔하이머성 치매치료용 경피흡수제제
KR100438254B1 (ko) 비타민 ｄ 유사체를 포함하는 매트릭스형 경피흡수제제
JP2540861B2 (ja) 湿布剤
JP2001039873A (ja) 経皮吸収型排尿障害治療剤
JP2000281566A (ja) 経皮適用剤の改良された薬物放出の時間制御システム
KR20020037616A (ko) 케토롤락의 경피흡수제제
JPH05279254A (ja) クロニジン経皮投与製剤

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020412

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CRANE, LAURA J.

Owner name: SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC.

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040406